Bodal Chemicals Ltd has issued a clarification to BSE Surveillance regarding recent price and volume movements in its shares, responding to an inquiry dated 23rd March 2026. The company addressed concerns about unusual trading activity through an official communication signed by Company Secretary Ashutosh B. Bhatt.

Company's Response to BSE Inquiry

In response to BSE's surveillance inquiry with reference number L/SURV/ONL/PV/SJ/2025-2026/3457, Bodal Chemicals categorically stated that there is no undisclosed information or pending announcements that could impact the share's price or volume behavior. The company emphasized that management has no connection to the observed trading movements.

Market-Driven Movement Explanation

The company attributed the share price and volume fluctuations to purely market-driven factors and prevailing market conditions. Bodal Chemicals clarified that the trading behavior does not stem from any internal developments or material information that has not been disclosed to the exchanges.

Regulatory Compliance Commitment

Bodal Chemicals reaffirmed its adherence to regulatory requirements, specifically highlighting compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company assured that it maintains transparency by keeping stock exchanges informed of all material information as required under applicable regulations.

Official Communication Details

The clarification was digitally signed by Ashutosh Bharatkumar Bhatt, who serves as Company Secretary and Compliance Officer. The response was submitted on 23rd March 2026 at 18:25:17 hours, demonstrating the company's prompt response to regulatory inquiries.

Bodal Chemicals Limited announced its Q3FY26 financial results during a Board meeting held on February 14, 2026. The company reported consolidated quarterly results for the quarter and nine months ended December 31, 2025, under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Overview

The company's consolidated financial results showed mixed performance across different periods. For Q3FY26, total income reached Rs. 5,046.57 million compared to Rs. 4,453.67 million in Q3FY25, representing 13.30% growth in revenue generation. However, net profit declined significantly to Rs. 2.42 million from Rs. 54.15 million in the corresponding quarter of the previous year.

Strategic Land Sale Approvals

The Board approved two significant land disposal transactions as part of ongoing asset rationalization and monetization strategy. The first land sale involves 15.1875 acres at Unit-12 for a buyer who will set up a unit to consume the company's byproduct chlorine. The second covers 24.7083 acres at Unit-12 for a buyer who will consume the company's byproduct hydrogen, totaling 39.90 acres.

Operational Highlights and Challenges

The company implemented new Labour Codes effective November 21, 2025, resulting in increased gratuity liability of Rs. 17.97 million primarily due to changes in the definition of "wages" for employees and contract labours. During the nine months ended December 31, 2025, the company sold parts of Unit-II and Unit-III at Vatva, G.I.D.C., Ahmedabad, generating profit on sale included in Other Income.

Subsidiary Performance Impact

International subsidiaries showed mixed performance during Q3FY26. The company applied Ind AS 29 for its Turkish subsidiaries operating in hyperinflationary economies, resulting in a loss of Rs. 10.03 million for the quarter and Rs. 43.37 million for nine months ended December 31, 2025.

Trading Window and Compliance

The company announced that the trading window for dealing in securities will re-open from February 17, 2026. The Board meeting commenced at 11:50 a.m. and concluded at 1:10 p.m. on February 14, 2026, conducted through audio-visual means at the corporate office.